fbpx
 

Parallel consumable and instrument development is required to hit key milestones during fast-paced development programs. As the consumable complexity increases to meet the ever-growing demand of complex assay/chemistry processing or more data-driven medical devices, the instrument/consumable interface also grows in complexity and is typically a...

Key Tech is proud to announce six new team members who have joined us in the past several months. Learn more about the newest additions to our crew below. Top row in the image from left to right Ben Coudon, Electrical Engineer Graduated from: University of Maryland, College...

Blackbird Labs is a life sciences accelerator with a mission to develop Baltimore’s biotech startup ecosystem. Funded by the owners of the Baltimore Ravens, Blackbird’s focus is on bridging the gap between research labs and clinical trials. In Episode #32, Andy Rogers of Key Tech talks...

At Key Tech, we recognize the importance of being able to prototype quickly. Out-of-the-box ideas often require prototyping and testing to determine viability, and rapid prototyping allows us and our clients to efficiently reach a yes/no decision on if an idea is worth pursuing further....

Diversity and inclusion (D&I) are essential to sustainable business cultures, nowhere more so than in the MedTech industry, where a product’s success can depend on its acceptance within a variety of communities. In Episode #30, KeyTech’s Andy Rogers and Senior Mechanical Engineer Danica Mackesey sat down...

 Rivanna Medical is a Virginia-based developer of ultrasound imaging technologies. Accuro, the company’s first product, is a “stud finder for the spine” for more accurate needle placement during spinal and epidural procedures. In Episode #29, Andy Rogers of Key Tech talks with Rivanna’s Chairman, CEO, and...

Navigating startups from concept to market is a formidable challenge. Early-stage investors make a difference by guiding MedTech innovators to startup success. The Key Tech team recently met with Dr. Deborah Hemingway, Managing Partner at investment firm Ecphora Capital. Dr. Hemingway shared her perspective on Maryland’s...

As terrible as it was, the COVID-19 pandemic spurred many medical innovations, including accessible over-the-counter (OTC) diagnostic tests. In response to the COVID-19 pandemic, the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) program awarded funds to fast-track these innovative tests through the development pipeline...

Every challenge is different – Tell us about yours.